Skip to main content

Table 1 Description of samples included in this study by period of collection, gender, age and parasitemia

From: Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature

Region (N)b Period Gender (male,  %) Median age, years (IQRc) Parasitemia, geometric mean (range)d
Patients infected by P. falciparum a
 Amapá (10) 2004–2005 60 35 (27–46) 1306 (605–2500)
 Rondônia (4) 2008 75 42 (32–52) 5004 (1520–24,650)
Mato Grosso (18) 2002–2012 83 36 (26–43) 1505 (62–56,660)
Patients infected by P. vivax a
 Mato Grosso (13) 2005–2012 92 35 (17–49) 4816 (992–17,500)
 Rondônia (22) 2008 73 41 (23–50) 1840 (95–10,770)
  1. a First line treatment for uncomplicated P. falciparum malaria during sample collection: QN + doxycycline + PQ (2001–2007) and ACT (after 2007). Treatment scheme for P. vivax therapy: CQ + PQ [6]
  2. b State of sample collection and number of isolates analysed
  3. c Interquartile range
  4. d Parasites/µL